Volume 94 Issue 35 | p. 18 | Concentrates
Issue Date: September 5, 2016

AMRI to close former Euticals site

Department: Business
Keywords: pharmaceutical chemicals, personalized medicine, cell therapy, cancer, immuno-oncology

Albany Molecular Research Inc. (AMRI) has embarked on a restructuring in the wake of its May acquisition of the Italian pharmaceutical chemicals maker Euticals for $358 million. AMRI says it will close a Euticals facility and lay off an undisclosed number of workers in the U.S. and Europe by the end of the year. AMRI expects to incur a onetime charge of up to $7.3 million.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment